Literature DB >> 22796228

Manifesto for a European research network into obsessive-compulsive and related disorders.

N A Fineberg, D S Baldwin, J M Menchon, D Denys, E Grünblatt, S Pallanti, D J Stein, J Zohar.   

Abstract

Obsessive-compulsive and related disorders (O-CRDs) are highly disabling psychiatric illnesses of early-onset. They are responsible for considerable morbidity and socioeconomic burden. Existing treatments are usually only partially successful and there is an urgent need to understand the aetiological factors and neurobiological bases of the disorders in order to develop new and more effective strategies for prevention, early detection and effective treatment. Emerging data from the neurosciences supports the reconceptualisation of obsessive-compulsive disorder as a spectrum disorder, related to but different from the anxiety disorders and closely aligned with other less well understood psychiatric disorders characterised by compulsive acts such as body dysmorphic disorder, trichotillomania, skin-picking disorder, hoarding disorder; and possibly extending to tic disorders and other neurodevelopmental disorders such as autism. A new, O-CRDs research network, supported by the Networks Initiative of the European College of Neuropsychopharmacology and comprising leading figures in preclinical and clinical research, has been established. It aims to provide a European perspective on the current debate around internationally-accepted diagnostic criteria and treatment strategies for O-CRDs. Its objectives include; (1) identifying the key outstanding research questions that depend upon cross-centre collaborative investigation, (2) setting a research agenda that is likely to produce an impact on health-outcomes, and (3) strengthening existing projects and collaborative enterprises with these objectives in mind. This paper reviews some of these critical research priorities. By establishing shared multinational databases, collaborative research networks, multicentre studies and joint publications, it is hoped that progress will be achieved.
Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22796228     DOI: 10.1016/j.euroneuro.2012.06.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  5 in total

Review 1.  Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment.

Authors:  Naomi A Fineberg; Annemieke M Apergis-Schoute; Matilde M Vaghi; Paula Banca; Claire M Gillan; Valerie Voon; Samuel R Chamberlain; Eduardo Cinosi; Jemma Reid; Sonia Shahper; Edward T Bullmore; Barbara J Sahakian; Trevor W Robbins
Journal:  Int J Neuropsychopharmacol       Date:  2018-01-01       Impact factor: 5.176

2.  A multilevel longitudinal study of obsessive compulsive symptoms in adolescence: male gender and emotional stability as protective factors.

Authors:  Vasilis Stavropoulos; Kathleen A Moore; Helen Lazaratou; Dimitris Dikaios; Rapson Gomez
Journal:  Ann Gen Psychiatry       Date:  2017-11-22       Impact factor: 3.455

3.  Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.

Authors:  Naomi A Fineberg; David S Baldwin; Lynne M Drummond; Solange Wyatt; Jasmine Hanson; Srinivas Gopi; Sukhwinder Kaur; Jemma Reid; Virender Marwah; Ricky A Sachdev; Ilenia Pampaloni; Sonia Shahper; Yana Varlakova; Davis Mpavaenda; Christopher Manson; Cliodhna O'Leary; Karen Irvine; Deela Monji-Patel; Ayotunde Shodunke; Tony Dyer; Amy Dymond; Garry Barton; David Wellsted
Journal:  Int Clin Psychopharmacol       Date:  2018-11       Impact factor: 1.659

4.  Patient satisfaction with specialized mental health service for obsessive-compulsive disorder.

Authors:  Paraskevi Mavrogiorgou; Frauke Siebers; Georg Juckel; Thorsten Kienast
Journal:  Ann Gen Psychiatry       Date:  2013-12-16       Impact factor: 3.455

5.  Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD).

Authors:  Eduardo Cinosi; David Adam; Ibrahim Aslan; David Baldwin; Kieran Chillingsworth; Arun Enara; Tim Gale; Kabir Garg; Matthew Garner; Robert Gordon; Natalie Hall; Nathan T M Huneke; Sonay Kucukterzi-Ali; Joanne McCarthy; Daniel Meron; Deela Monji-Patel; Roisin Mooney; Trevor Robbins; Megan Smith; Nick Sireau; David Wellsted; Solange Wyatt; Naomi A Fineberg
Journal:  Pilot Feasibility Stud       Date:  2021-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.